Shannon Eisenhardt Sells 1,368 Shares of Reckitt Benckiser Group plc (LON:RKT) Stock

Reckitt Benckiser Group plc (LON:RKTGet Free Report) insider Shannon Eisenhardt sold 1,368 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of GBX 4,723 ($59.61), for a total transaction of £64,610.64 ($81,548.20).

Reckitt Benckiser Group Stock Up 0.4 %

RKT stock opened at GBX 4,857 ($61.30) on Friday. The firm has a market capitalization of £33.57 billion, a PE ratio of 2,238.25, a P/E/G ratio of 1.10 and a beta of 0.09. The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 112.52. Reckitt Benckiser Group plc has a twelve month low of GBX 4,034 ($50.92) and a twelve month high of GBX 5,886.44 ($74.30). The stock’s 50 day moving average is GBX 4,785.46 and its 200-day moving average is GBX 4,525.03.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on RKT. JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group to a “neutral” rating in a research report on Friday, August 30th. Berenberg Bank dropped their target price on shares of Reckitt Benckiser Group from GBX 5,200 ($65.63) to GBX 5,177 ($65.34) and set a “hold” rating on the stock in a research report on Wednesday, October 23rd.

Get Our Latest Analysis on RKT

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Further Reading

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.